October 02, 2014 11:53 AM ET

Pharmaceuticals

Company Overview of CollaGenex Pharmaceuticals, Inc.

Company Overview

CollaGenex Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets proprietary medical therapies to the dermatology market. Its lead development candidates include COL-118, a topical compound for the treatment of erythema (skin redness) associated with dermatological conditions; becocalcidiol, a vitamin D analogue, which is in a Phase II dose-finding clinical trial for the topical treatment of psoriasis; and Restoraderm, a proprietary foam-based, topical dermal drug delivery system. The company offers Oracea for the treatment of inflammatory lesions (papules and pustules) of rosacea in adult patients; Alcortin, a prescription topical antifungal steroid combination; an...

41 University Drive

Newtown, PA 18940

United States

Founded in 1992

147 Employees

Phone:

215-579-7388

Fax:

215-579-8577

Key Executives for CollaGenex Pharmaceuticals, Inc.

Vice President
Vice President
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
PureMeds, Inc. United States
Vitaelin Nutraceuticals, LLC United States
Therabiol, Inc. United States
Biomedica Management Corporation United States
T3D Therapeutics, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CollaGenex Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.